Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
PRICE
Prev Close
7.18
Open
7.18
Day Range7.18 – 7.68
7.18
7.68
52W Range3.43 – 11.25
3.43
11.25
51% of range
50-Day MA
5.19(+42.6%)
200-Day MA
6.33(+17.0%)
VOLUME & SIZE
Avg Volume
2.5M
FUNDAMENTALS
P/E (TTM)
-3.0x
Not profitable
EPS (TTM)
—
Div Yield (TTM)
No dividend
Beta
1.49
Market-like
TECHNICAL
RSI (14)
62
Bullish momentum
VSTM News
About
Buy19 analysts
Target $13.50+82.4%
verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com